Glaucoma diagnosis may be mistaken in some younger Chinese people

March 21, 2007

STANFORD, Calif. - Many young and middle-aged people of Chinese ancestry told they are at risk of going blind from glaucoma may be getting incorrect information, say researchers at the Stanford University School of Medicine.

After following a cluster of 16 such patients for seven years and observing more than 100 others, the researchers have concluded that there's a new syndrome occurring in the Chinese population, and it may be less likely to lead to severe vision loss or blindness than typical glaucoma. Their results are published in the March issue of Ophthalmology.

Glaucoma is a condition that occurs from accumulating damage to cells whose fibers make up the optic nerve, which transmits information from the eye to the brain. This disease is the second-leading cause of blindness worldwide, affecting one in 200 people over the age of 50, but is less common in younger people.

So when Kuldev Singh, MD, MPH, professor of ophthalmology, began seeing a number of young Chinese males 15 years ago who had been diagnosed with glaucoma, he became suspicious that perhaps they had another syndrome.

"I started to see a lot of Chinese men with advanced glaucoma at a young age," said Singh. "Many of them were terrified. Most were otherwise healthy and active and thus were surprised that they had this disease."

Singh noticed that not only were these patients young Chinese males, but almost all were nearsighted and many had normal eye pressure. Most glaucoma patients have high eye pressure, which is thought to lead to optic nerve damage. To see so many similar patients including many with normal pressure was unusual.

"It would be equivalent to someone having a heart attack when they have normal cholesterol," he said.

The combination of similarities among the patients led Singh to question whether these individuals, including some as young as 25, had glaucoma rather than another syndrome. So instead of the normal, aggressive course of treatment for young glaucoma patients - including surgery - Singh kept most of the patients on low doses of pressure-lowering eye drops as a precaution. As he suspected, none of the patients progressed toward blindness during the course of the study.

Singh began sharing his experience with doctors around the world and found he was not the only one with patients with these symptoms. Frequently, he said, a doctor in an online forum would describe a puzzling case of a young man with unexplained glaucoma. Singh would respond, "Is he nearsighted and is he Chinese?" and the doctor would respond, "How did you know?"

Singh said he thinks that optic nerve damage in these patients is caused by their nearsightedness, and that others have reported that nearsightedness is increasing in the Chinese population.

Nearsightedness is caused by a lengthening of the eye, and Singh and colleagues suggested in the paper that stretching the eye can damage the optic nerve. Since nearsightedness rarely gets worse in people after their 30s, the optic nerve damage may ultimately slow or stabilize in such patients.

"Some might say that by classic definitions, all of these patients have glaucoma," said Singh, because they meet the optic nerve damage criteria for the disease. But a second criterion for glaucoma is that it leads to progressive vision loss, especially if not adequately treated.

The cluster of patients did not appear to be headed for blindness over the seven years they were followed. But Singh calls the findings preliminary, and said further studies are needed. "If they don't appear to be progressing toward blindness right now," he said, "they shouldn't be treated as if they have a blinding condition, especially since surgery is associated with significant risks."

Singh hopes his paper acts as a warning to doctors to look closely at this population when diagnosing glaucoma, so they won't rush patients to surgery when it's not needed. "I would say tread gently with that population," he noted.

In addition to the cluster of young Chinese men mentioned in the paper, Singh has also observed this condition in Chinese women. To determine exactly how prevalent this condition is, Singh and colleagues are now surveying young individuals of Chinese ancestry in the Stanford community. While it is too early to make definitive conclusions regarding this study, the group has preliminarily found a surprisingly high prevalence of optic nerve damage. "Our suspicion is that this is an epidemic," he said. But only time will tell whether these individuals have glaucoma.

Singh hopes, eventually, to explain why this condition appears more often in people of Chinese ancestry relative to other populations, and whether there is a gender difference. For now, he wonders whether the syndrome is related to reports from other researchers of a recent surge in nearsightedness among the Chinese.

"The next step is to try to learn more about the natural history and genetics of this condition," said Singh, "and see whether there are subsets of the population more prone to it."
-end-
Co-authors on the study included Stanford ophthalmology residents Amish Doshi, MD, and Lorianna Lombardi, MD, as well as former Stanford residents Ken Kreidl, MD, and Douglas Sakamoto, MD.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.

PRINT MEDIA CONTACT: Donna Alvarado at (650) 724-9949 (dalvarado@stanford.edu)
BROADCAST MEDIA CONTACT: M.A. Malone at (650) 723-6912 (mamalone@stanford.edu)

Stanford University Medical Center

Related Glaucoma Articles from Brightsurf:

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye.

Study finds novel mechanism that may confer protection against glaucoma
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma.

AI-supported test for very early signs of glaucoma progression
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.

New method gives glaucoma researchers control over eye pressure
Neuroscientists have developed a new method that permits continuous regulation of eye pressure without damage, becoming the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Glaucoma care in prison inmates
Data fromĀ 82 prison inmates treated in a glaucoma clinic at an academic hospital were used in this observational study to report on how treatment and follow-up, including medication adherence, were are managed.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.

UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.

Read More: Glaucoma News and Glaucoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.